New device aims to boost circulation and ward off dangerous clots

NCT ID NCT05511064

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a device called CGM MB-1701 to see if it can improve blood flow in people at risk for deep vein thrombosis (DVT). The study enrolled 60 adults who did not have DVT at the start. Researchers measured changes in blood flow speed in the leg vein after using the device for 5 and 10 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CGM MB-1701 blood circulation device

What this could lead to

If it works, this device could help prevent dangerous blood clots in people at risk for deep vein thrombosis.

What could go wrong

This is a small, early-stage trial with only 60 participants. The device may not prove effective or safe in larger, more diverse groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vascular disorder venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korea University Guro Hospital

    Seoul, South Korea

  • Presbyterian Medical Center

    Jeonju, South Korea

  • Seoul National University Bundang Hospital

    Seoul, South Korea